Rituximab in patients with refractory thrombotic thrombocytopenic purpura
Authors:
Open Access
- 6 April 2004
- journal article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 2 (5) , 834-836
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Remission of Chronic Thrombotic Thrombocytopenic Purpura after Treatment with Cyclophosphamide and RituximabAnnals of Internal Medicine, 2003
- Rituximab in the treatment of acquired factor VIII inhibitorsBlood, 2002
- Successful treatment of severe thrombotic thrombocytopenic purpura with the monoclonal antibody rituximabAmerican Journal of Hematology, 2002
- Rituximab Therapy for Refractory Thrombotic Thrombocytopenic PurpuraBlood Cells, Molecules, and Diseases, 2002
- Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpuraBlood, 2001
- Antibodies to von Willebrand Factor–Cleaving Protease in Acute Thrombotic Thrombocytopenic PurpuraNew England Journal of Medicine, 1998
- von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic SyndromeNew England Journal of Medicine, 1998